世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
希少腎疾患の世界市場レポート 2023年以下を含む1）対象疾患別IgA腎症、ループス腎炎、巣状分節性糸球体硬化症、膜性腎症、C3糸球体症2) 分子のタイプ別：低分子；生物製剤3) 投与経路別：経口；静脈内；皮下Merck & Co：対象：Merck & Co.Inc.、Novartis AG、Sanofi S.A.、AstraZeneca plc、GlaxoSmithKline plcRare Kidney Diseases Global Market Report 2023Including: 1) By Target Indication: IgA Nephropathy; Lupus Nephritis; Focal Segmental Glomerular Sclerosis; Membranous Nephropathy; C3 Glomerulopathy2) By Type of Molecule: Small Molecules; Biologics3) By Route of administration: Oral; Intravenous; SubcutaneousCovering: Merck & Co. Inc.; Novartis AG; Sanofi S.A; AstraZeneca plc; GlaxoSmithKline plc The Business Research Companyの希少腎臓病の世界市場レポート2023年は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。 このレポートは力強い成長を遂げて... もっと見る
サマリーThe Business Research Companyの希少腎臓病の世界市場レポート2023年は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。このレポートは力強い成長を遂げている希少腎臓病市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。 購入の理由 - 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。 - 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。 - ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。 - 世界的な高インフレが市場成長に与える影響を測定する。 - 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。 - 最新の市場シェアに基づいて顧客を理解する。 - 主要な競合他社に対する業績のベンチマーク - 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。 - レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3～5営業日以内にお届けします。 - レポートの全データは、エクセルのダッシュボード形式でも納品されます。 説明 希少腎臓病市場が最も大きく急成長しているのはどこか？経済全体、人口動態、他の類似市場との関連は？今後どのような力が市場を形成していくのか？ビジネスリサーチ社の希少腎疾患市場グローバルレポートは、これらすべての質問とその他多くの質問に回答します。 当レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、トレンド、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。 - 市場特性のセクションでは、市場を定義し説明しています。 - 市場規模のセクションでは、市場の歴史的な成長と発展の予測の両方をカバーする市場規模（bドル）を示します。 - 予測は、現在市場に影響を与えている主な要因を考慮した上で行っています。これらには以下が含まれる： - ロシア・ウクライナ戦争による制裁措置、サプライチェーンの混乱、商品・サービス需要の変化による影響、東欧地域の様々なマクロ経済要因やパラメータへの影響、その後の世界市場への影響。 - 多くの国々におけるインフレ率の上昇とそれに伴う金利の急上昇の影響。 - COVID-19がサプライチェーンと消費パターンに与える影響の継続と減少。 - 市場セグメンテーションでは、市場をサブマーケットに分類している。 - 地域別および国別の内訳では、各地域の市場分析と地域別の市場規模を示し、それらの過去および予測成長率を比較している。全地域、主要先進国、主要新興国のCOVID-19の成長軌跡を網羅しています。 - 競合環境の章では、市場の競合性、市場シェア、主要企業について解説しています。近年市場を形成してきた主要な金融取引についても明らかにしている。 - トレンドと戦略の章では、危機から脱した市場の形状を分析し、市場が回復する中で企業がどのように成長できるかを示唆している。 調査範囲 対象市場：1）適応症別IgA腎症；ループス腎炎；巣状分節性糸球体硬化症；膜性腎症；C3糸球体症；その他の適応症 2) 分子の種類別低分子；生物製剤 3) 投与経路別経口；静脈内；皮下；その他の投与経路 言及された企業Merck & Co.Inc、Novartis AG、Sanofi S.A、AstraZeneca plc、GlaxoSmithKline plc 国オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列：過去5年間および過去10年間の予測。 データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、 データ区分：国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。 ソーシングと参照：本レポート中のデータおよび分析は、エンドノートを使用しています。 納品形式PDF、Word、Excel データダッシュボード。 目次1. Executive Summary2. Rare Kidney Diseases Market Characteristics 3. Rare Kidney Diseases Market Trends And Strategies 4. Rare Kidney Diseases Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Rare Kidney Diseases Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Rare Kidney Diseases Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Rare Kidney Diseases Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Rare Kidney Diseases Market Segmentation 6.1. Global Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion IgA Nephropathy Lupus Nephritis Focal Segmental Glomerular Sclerosis Membranous Nephropathy C3 Glomerulopathy Other Target Indications 6.2. Global Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Small Molecules Biologics 6.3. Global Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Oral Intravenous Subcutaneous Other Routes of Administration 7. Rare Kidney Diseases Market Regional And Country Analysis 7.1. Global Rare Kidney Diseases Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Rare Kidney Diseases Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Rare Kidney Diseases Market 8.1. Asia-Pacific Rare Kidney Diseases Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Rare Kidney Diseases Market 9.1. China Rare Kidney Diseases Market Overview 9.2. China Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Rare Kidney Diseases Market 10.1. India Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Rare Kidney Diseases Market 11.1. Japan Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Rare Kidney Diseases Market 12.1. Australia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Rare Kidney Diseases Market 13.1. Indonesia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Rare Kidney Diseases Market 14.1. South Korea Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Rare Kidney Diseases Market 15.1. Western Europe Rare Kidney Diseases Market Overview 15.2. Western Europe Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Rare Kidney Diseases Market 16.1. UK Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Rare Kidney Diseases Market 17.1. Germany Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Rare Kidney Diseases Market 18.1. France Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Rare Kidney Diseases Market 19.1. Italy Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Rare Kidney Diseases Market 20.1. Spain Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Rare Kidney Diseases Market 21.1. Eastern Europe Rare Kidney Diseases Market Overview 21.2. Eastern Europe Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Rare Kidney Diseases Market 22.1. Russia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Rare Kidney Diseases Market 23.1. North America Rare Kidney Diseases Market Overview 23.2. North America Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Rare Kidney Diseases Market 24.1. USA Rare Kidney Diseases Market Overview 24.2. USA Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Rare Kidney Diseases Market 25.1. Canada Rare Kidney Diseases Market Overview 25.2. Canada Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Rare Kidney Diseases Market 26.1. South America Rare Kidney Diseases Market Overview 26.2. South America Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Rare Kidney Diseases Market 27.1. Brazil Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Rare Kidney Diseases Market 28.1. Middle East Rare Kidney Diseases Market Overview 28.2. Middle East Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Rare Kidney Diseases Market 29.1. Africa Rare Kidney Diseases Market Overview 29.2. Africa Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Rare Kidney Diseases Market Competitive Landscape And Company Profiles 30.1. Rare Kidney Diseases Market Competitive Landscape 30.2. Rare Kidney Diseases Market Company Profiles 30.2.1. Merck & Co. Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Novartis AG 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Sanofi S.A 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. AstraZeneca plc 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. GlaxoSmithKline plc 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Rare Kidney Diseases Market Other Major And Innovative Companies 31.1. Otsuka Pharmaceutical Co Ltd. 31.2. Alexion Pharmaceuticals Inc. 31.3. Horizon Therapeutics plc. 31.4. Recordati S.p.A. 31.5. Proteostasis Therapeutics 31.6. Amicus Therapeutics Inc. 31.7. Akebia Therapeutics Inc. 31.8. Travere Therapeutics 31.9. FibroGen Inc. 31.10. Aurinia Pharmaceuticals Inc. 31.11. Calliditas Therapeutics AB 31.12. Apellis Pharmaceuticals Inc. 31.13. Protalix Biotherapeutics Inc. 31.14. ChemoCentryx Inc. 31.15. Omeros Corporation 32. Global Rare Kidney Diseases Market Competitive Benchmarking 33. Global Rare Kidney Diseases Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Rare Kidney Diseases Market 35. Rare Kidney Diseases Market Future Outlook and Potential Analysis 35.1 Rare Kidney Diseases Market In 2027 - Countries Offering Most New Opportunities 35.2 Rare Kidney Diseases Market In 2027 - Segments Offering Most New Opportunities 35.3 Rare Kidney Diseases Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
SummaryRare Kidney Diseases Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. Table of Contents1. Executive Summary2. Rare Kidney Diseases Market Characteristics 3. Rare Kidney Diseases Market Trends And Strategies 4. Rare Kidney Diseases Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Rare Kidney Diseases Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Rare Kidney Diseases Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Rare Kidney Diseases Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Rare Kidney Diseases Market Segmentation 6.1. Global Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion IgA Nephropathy Lupus Nephritis Focal Segmental Glomerular Sclerosis Membranous Nephropathy C3 Glomerulopathy Other Target Indications 6.2. Global Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Small Molecules Biologics 6.3. Global Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Oral Intravenous Subcutaneous Other Routes of Administration 7. Rare Kidney Diseases Market Regional And Country Analysis 7.1. Global Rare Kidney Diseases Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Rare Kidney Diseases Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Rare Kidney Diseases Market 8.1. Asia-Pacific Rare Kidney Diseases Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Rare Kidney Diseases Market 9.1. China Rare Kidney Diseases Market Overview 9.2. China Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Rare Kidney Diseases Market 10.1. India Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Rare Kidney Diseases Market 11.1. Japan Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Rare Kidney Diseases Market 12.1. Australia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Rare Kidney Diseases Market 13.1. Indonesia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Rare Kidney Diseases Market 14.1. South Korea Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Rare Kidney Diseases Market 15.1. Western Europe Rare Kidney Diseases Market Overview 15.2. Western Europe Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Rare Kidney Diseases Market 16.1. UK Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Rare Kidney Diseases Market 17.1. Germany Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Rare Kidney Diseases Market 18.1. France Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Rare Kidney Diseases Market 19.1. Italy Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Rare Kidney Diseases Market 20.1. Spain Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Rare Kidney Diseases Market 21.1. Eastern Europe Rare Kidney Diseases Market Overview 21.2. Eastern Europe Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Rare Kidney Diseases Market 22.1. Russia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Rare Kidney Diseases Market 23.1. North America Rare Kidney Diseases Market Overview 23.2. North America Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Rare Kidney Diseases Market 24.1. USA Rare Kidney Diseases Market Overview 24.2. USA Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Rare Kidney Diseases Market 25.1. Canada Rare Kidney Diseases Market Overview 25.2. Canada Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Rare Kidney Diseases Market 26.1. South America Rare Kidney Diseases Market Overview 26.2. South America Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Rare Kidney Diseases Market 27.1. Brazil Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Rare Kidney Diseases Market 28.1. Middle East Rare Kidney Diseases Market Overview 28.2. Middle East Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Rare Kidney Diseases Market 29.1. Africa Rare Kidney Diseases Market Overview 29.2. Africa Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Rare Kidney Diseases Market Competitive Landscape And Company Profiles 30.1. Rare Kidney Diseases Market Competitive Landscape 30.2. Rare Kidney Diseases Market Company Profiles 30.2.1. Merck & Co. Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Novartis AG 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Sanofi S.A 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. AstraZeneca plc 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. GlaxoSmithKline plc 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Rare Kidney Diseases Market Other Major And Innovative Companies 31.1. Otsuka Pharmaceutical Co Ltd. 31.2. Alexion Pharmaceuticals Inc. 31.3. Horizon Therapeutics plc. 31.4. Recordati S.p.A. 31.5. Proteostasis Therapeutics 31.6. Amicus Therapeutics Inc. 31.7. Akebia Therapeutics Inc. 31.8. Travere Therapeutics 31.9. FibroGen Inc. 31.10. Aurinia Pharmaceuticals Inc. 31.11. Calliditas Therapeutics AB 31.12. Apellis Pharmaceuticals Inc. 31.13. Protalix Biotherapeutics Inc. 31.14. ChemoCentryx Inc. 31.15. Omeros Corporation 32. Global Rare Kidney Diseases Market Competitive Benchmarking 33. Global Rare Kidney Diseases Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Rare Kidney Diseases Market 35. Rare Kidney Diseases Market Future Outlook and Potential Analysis 35.1 Rare Kidney Diseases Market In 2027 - Countries Offering Most New Opportunities 35.2 Rare Kidney Diseases Market In 2027 - Segments Offering Most New Opportunities 35.3 Rare Kidney Diseases Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
The Business Research Company (TBRC)社の医薬分野での最新刊レポート
本レポートと同じKEY WORD（kidney diseases）の最新刊レポートよくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |
